Fusion Antibodies News

One size fits all: A bispecific antigen toolkit for antibody discovery and screening

Fusion Antibodies have harnessed a bispecific antigen toolkit for antibody discovery and screening.

Appointment of Chief Executive Officer

Fusion Antibodies plc announces the appointment of Dr Adrian Kinkaid as Chief Executive Officer.
Fusion Antibodies Announces Formation of Scientific Advisory Panel

Fusion Antibodies plc Announces Formation of New Scientific Advisory Panel

World-renowned experts in the fields of antibody engineering Matthew Baker Ph.D., Professor Terry Rabbitts, and Professor Charlotte Deane to join Fusion Antibodies Scientific Advisory Panel
Inclusion of Omicron RBD into development programme

Omicron introduced to Fusion Antibodies R&D Catalogue

Fusion Antibodies has decided to include Omicron RBD, alongside the alpha, beta, gamma and delta+ RBD variants, in its development programme with the aim of producing virus-neutralising antibodies.

Fusion Antibodies RAMPs Up Collaboration Success

New $1.83 million R&D project win for Fusion Antibodies reinforces its position as one of the leading providers of early-stage antibody discovery and engineering services.
Eurofins Discovery Partnership

Fusion Antibodies partners with Eurofins Discovery to support innovative preclinical drug discovery research

Fusion Antibodies and Eurofins Discovery sign co-marketing agreement to support timely and cost-effective development of innovative products for the benefit of global healthcare
Fusion Antibodies Supply banner

Supporting Indian Biotherapeutic Companies with Antibody Development

Fusion Antibodies, pre-clinical antibody discovery and development experts and BioTickle, their exclusive distributor in India, are providing local biopharmaceutical organisations with access to invaluable unique biopharmaceutical development capabilities.
Translating Linen 'State of the Art' Project

Fusion Antibodies proud to support ‘State of the Art’ project

NI Science Festival, in conjunction with Linen Biennale recently rolled out the virtual red carpet to premier Dr Anthony O’Kane’s ‘Translating Linen.’
Platinum Level Innovator Award

Fusion Antibodies awarded Platinum Level Innovator Status by Innovate NI

Fusion Antibodies is delighted to be recognised as a Platinum Level Innovator in the Innovate NI Innovation Accreditation programme from the Department for the Economy.

Fusion Antibodies and Queen’s University Belfast Receive Grant to Boost R&D for COVID-19 Antibodies

Fusion Antibodies and Queen’s University Belfast Receive £453,000 grant from Invest Northern Ireland to Boost Research and Development for COVID-19 Antibodies

200 Reasons to Celebrate!

Fusion Antibodies are celebrating their 200th Antibody Humanization project, cementing our place as a leading CRO in antibody engineering services.

Studies prove antigens created by Fusion Antibodies accurately identify SARS-CoV-2

Fusion Antibodies have leveraged their antigen expertise to create multiple antigens to be used against the COVID-19 pandemic.